Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A07XA04	RACECADOTRIL ARROW	G	Racecadotril - 100mg	100mg	Capsule	583,228 L.L
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.5%	Injectable solution	148,566 L.L
C05AE01	RECTOGESIC	G	Glyceryl trinitrate - 0.2% w/w	0.2% w/w	Ointment	2,553,301 L.L
C09CA04	ZIOREL	G	Irbesartan - 300mg	300mg	Tablet, film coated	575,933 L.L
C10AA07	ROSUVAS	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	450,187 L.L
D10AD51	CLINIDERM T	G	Tretinoin - 0.025%, Clindamycin (phosphate) - 1%		Gel	801,186 L.L
G04BE09	LEVIDOR	G	Vardenafil (HCl) - 5mg	5mg	Tablet	876,185 L.L
J01DC02	CEFUROXIME – PANPHARMAPOUDRE POUR SOLUTION INJ. IM/IV	G	Cefuroxime (sodium) - 750mg	750mg	Injectable powder for solution	1,651,582 L.L
J01MA12	OXALEV	G	Levofloxacin - 500mg	500mg	Tablet, film coated	791,523 L.L
L04AA29	TRIJAN	G	Tofacitinib - 10mg	10mg	Tablet, film coated	84,793,962 L.L
M01AH01	CELECOXIB ARROW LAB	G	Celecoxib - 200mg	200mg	Capsule	561,726 L.L
N02BE01	PARACETAMOL	G	Paracetamol - 500mg	500mg	Tablet	66,552 L.L
N04BC07	DACEPTON	G	Apomorphine HCl - 30mg/3ml	30mg/3ml	Injectable solution	13,404,432 L.L
N06AX16	DEPREVIX HELLAS	G	Venlafaxine - 75mg	75mg	Capsule, prolonged release	564,414 L.L
R03AK07	BUFOMIX EASYHALER	G	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 160mcg/inhalation		Metered dose inhaler	2,365,163 L.L
S01AA09	TETRACYCLINE EYE OINTMENT	G	Tetracycline HCl - 1%	1%	Ointment	71,672 L.L
A02BC02	PANTOMAX	G	Pantoprazole (sodium sesquihydrate) - 20mg	20mg	Tablet, enteric coated	837,214 L.L
A07XA04	RACECADOTRIL BGR	G	Racecadotril - 100mg	100mg	Capsule	575,165 L.L
B05CX01	DEXTROSE 7.5% INJECTION USP	G	Glucose - 7.5%	7.5%	Injectable solution	179,456 L.L
C05AE03	DILTIGEL	G	Diltiazem HCl - 2%	2%	Gel	632,950 L.L
C10AA07	ROVASTIN	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet	618,168 L.L
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.025%, Clindamycin (phosphate) - 1%		Gel	801,186 L.L
J01DC02	CEFUZIME	G	Cefuroxime (sodium) - 750mg	750mg	Injectable dry powder	147,823 L.L
J01MA12	OXALEV	G	Levofloxacin - 500mg	500mg	Tablet, film coated	565,758 L.L
L01EX01	SOVIDEX	G	Sunitinib maleate - 25mg	25mg	Capsule	64,804,314 L.L
M01AH01	CELECOXIB BIOGARAN	G	Celecoxib - 200mg	200mg	Capsule	638,325 L.L
N02BE01	PARACETAMOL	G	Paracetamol - 500mg	500mg	Tablet	3,161,230 L.L
N04BC07	DACEPTON	G	Apomorphine HCl Hemihydrate - 100mg/20ml	100mg/20ml	Injectable solution	12,678,532 L.L
N06AX16	DEPREVIX HELLAS	G	Venlafaxine - 75mg	75mg	Capsule, prolonged release	564,414 L.L
R03AK07	BUFOMIX EASYHALER	G	Formoterol fumarate dihydrate - 4.5mcg/inhalation, Budesonide - 160mcg/inhalation		Metered dose inhaler	1,182,581 L.L